GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-13.92%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$123M
AUM Growth
+$123M
Cap. Flow
-$80.9M
Cap. Flow %
-65.78%
Top 10 Hldgs %
50.69%
Holding
71
New
19
Increased
Reduced
22
Closed
21
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
XBI icon
51
SPDR S&P Biotech ETF
XBI
$5.29B
0
TVTX icon
52
Travere Therapeutics
TVTX
$1.75B
-200,000
Closed -$3.86M
TNXP icon
53
Tonix Pharmaceuticals
TNXP
$243M
0
-350,000
-100% -$2.69M
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.98B
-100,000
Closed -$3.86M
RGNX icon
55
Regenxbio
RGNX
$498M
-60,000
Closed -$996K
PRTA icon
56
Prothena Corp
PRTA
$452M
-90,000
Closed -$6.13M
PCRX icon
57
Pacira BioSciences
PCRX
$1.22B
-30,000
Closed -$2.3M
LAB icon
58
Standard BioTools
LAB
$493M
-150,000
Closed -$1.62M
IWM icon
59
iShares Russell 2000 ETF
IWM
$66.6B
0
INCY icon
60
Incyte
INCY
$17B
-50,000
Closed -$5.42M
FOLD icon
61
Amicus Therapeutics
FOLD
$2.42B
0
EW icon
62
Edwards Lifesciences
EW
$47.7B
0
DVAX icon
63
Dynavax Technologies
DVAX
$1.19B
-55,000
Closed -$1.33M
CPRX icon
64
Catalyst Pharmaceutical
CPRX
$2.42B
-376,000
Closed -$921K
BLUE
65
DELISTED
bluebird bio
BLUE
-120,000
Closed -$7.71M
BIIB icon
66
Biogen
BIIB
$20.8B
-25,000
Closed -$7.66M
BHC icon
67
Bausch Health
BHC
$2.72B
0
AMGN icon
68
Amgen
AMGN
$153B
-75,000
Closed -$12.2M
ALNY icon
69
Alnylam Pharmaceuticals
ALNY
$58.6B
-45,000
Closed -$4.24M
ABBV icon
70
AbbVie
ABBV
$374B
0
TEVA icon
71
Teva Pharmaceuticals
TEVA
$21.5B
0